πŸ‡ΊπŸ‡Έ FDA
Patent

US 6262047

Selective factor Xa inhibitors

expired A61KA61K38/00A61P

Quick answer

US patent 6262047 (Selective factor Xa inhibitors) held by COR Therapeutics, Inc. expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue Jul 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P7/02